Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parathyroid tumors.

Tobias Carling1, Robert Udelsman

  • 1Department of Surgery, Yale University School of Medicine, 330 Cedar Street, FMB 102, Box 208062, New Haven, CT 06510, USA.

Current Treatment Options in Oncology
|August 29, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tailored Vein Sampling and Surgery in Primary Aldosteronism.

JAMA surgery·2026
Same author

Molecular pathology of primary aldosteronism and hypercortisolism: Impact on adrenal surgery.

iScience·2026
Same author

Preventing Cushing Syndrome: Adrenalectomy in <i>PDE11A</i>-Positive Primary Pigmented Nodular Adrenocortical Disease.

JCEM case reports·2026
Same author

Massive Pheochromocytomatosis Treated With Cytoreductive Surgery.

JCEM case reports·2026
Same author

Primary aldosteronism: adrenalectomy could save more lives.

Frontiers in endocrinology·2025
Same author

Mild Autonomous Cortisol Secretion in Congenital Adrenal Hyperplasia Managed With Mini Back Scope Adrenalectomy.

JCEM case reports·2025
Same journal

Interaction between Regulated Cell Death Pathways and Core Cellular Processes: Unraveling the Molecular Mechanisms of Cardiotoxicity of Antitumor Drugs.

Current treatment options in oncology·2026
Same journal

Advances in Immunotherapy for Breast Cancer: Up-to-date Strategies of Immune Checkpoint Inhibitors and Therapeutic Vaccines.

Current treatment options in oncology·2026
Same journal

Recent Advances in Neoadjuvant Treatment of Anaplastic Thyroid Carcinoma: A Narrative Review.

Current treatment options in oncology·2026
Same journal

The Immunological Landscape of the Tumor Microenvironment: Implications for Immunotherapy of Unresectable and Metastatic Soft Tissue Sarcomas.

Current treatment options in oncology·2026
Same journal

Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer.

Current treatment options in oncology·2026
Same journal

Emerging Applications of CAR-T Cell Therapy in Overcoming Resistance and Expanding Targets in Hematologic Malignancies: Insights from Recent Research.

Current treatment options in oncology·2026
See all related articles

Primary hyperparathyroidism, often undiagnosed, is treatable with surgery. Surgical intervention, especially minimally invasive techniques, offers significant benefits for patients, including reversal of bone disease and neuropsychologic symptoms.

Area of Science:

  • Endocrinology
  • Surgical Oncology

Background:

  • Primary hyperparathyroidism (PHPT) is a common endocrine disorder.
  • Many cases remain undiagnosed despite uncomplicated diagnostic work-up.
  • Delayed diagnosis often leads to a lack of appropriate curative surgical treatment.

Purpose of the Study:

  • To highlight the importance of surgical intervention for primary hyperparathyroidism.
  • To emphasize the benefits of surgery, even in mild asymptomatic cases.
  • To advocate for referral to endocrine surgeons for treatment discussions.

Main Methods:

  • Review of recent studies on surgical outcomes in PHPT.
  • Analysis of the efficacy of minimally invasive surgical techniques.
  • Evaluation of benefits in reversing disease-related symptoms.

Related Experiment Videos

Main Results:

  • Surgery is beneficial for primary hyperparathyroidism, including mild asymptomatic disease.
  • Surgical intervention effectively reverses bone disease, neuropsychologic symptoms, and dyslipoproteinemia.
  • Minimally invasive surgery demonstrates high success rates and low morbidity.

Conclusions:

  • All patients with primary hyperparathyroidism should be considered for surgical referral.
  • Minimally invasive surgical techniques are evolving and becoming the standard of care.
  • Timely surgical treatment is crucial for improving patient outcomes in PHPT.